Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Irene Cecchini"'
Autor:
Irene Cecchini
Publikováno v:
Romance Notes. 61:39-51
Attraverso la lettura di Verso la foce di Gianni Celati e Vento forte tra Lacedonia e Candela. Esercizi di paesologia di Franco Arminio, l'articolo vuole mettere in luce alcuni espedienti letterari utilizzati dagli scrittori per attuare una pratica n
Autor:
Alessandra Pistacchio, Fabio Baroni, Irene Cecchini, Roberta Verani, Mariano Stornaiuolo, Angelo Palmese, Carlo Pergola
Publikováno v:
European Journal of Pharmaceutical Sciences. 172:106139
A key aspect that must be supervised during the development of a biotherapeutic is the presence of elemental impurities in the final drug product: they must be quantified as to ensure that their concentrations does not affect patients’ safety. Regu
Autor:
Irene Cecchini
Publikováno v:
Narrativa. :194-195
Autor:
Paolo Mangiagalli, Thomas Spitznagel, Michael Rosario Defelippis, Andrew Weiskopf, Bernardo Perez-Ramirez, Hanns-Christian Mahler, Douglas P. Nesta, Atanas Koulov, Patrick Garidel, Robert Simler, Klaus Wuchner, Irene Cecchini, Patricia W. Cash, Vincent Corvari, Linda O. Narhi, Mara Rossi, Roland Schmidt, Shawn Cao, Tony Lubiniecki, Alla Polozova, Andrea Herre, Satish K. Singh, Nataliya Afonina
Publikováno v:
Biologicals : journal of the International Association of Biological Standardization. 43(6)
Measurement and characterization of subvisible particles (including proteinaceous and non-proteinaceous particulate matter) is an important aspect of the pharmaceutical development process for biotherapeutics. Health authorities have increased expect
Autor:
Irene Cecchini, Paolo Mangiagalli, Robert Simler, Hanns-Christian Mahler, Douglas P. Nesta, Patrick Garidel, Dean C. Ripple, Atanas Koulov, Mara Rossi, Bernardo Perez-Ramirez, Satish K. Singh, Thomas Spitznagel, Alla Polozova, Andrew Weiskopf, Nataliya Afonina, Linda O. Narhi, Andrea Herre, Roland Schmidt, Tony Lubiniecki, Vincent Corvari, Michael Rosario Defelippis, Klaus Wuchner
Publikováno v:
Journal of pharmaceutical sciences. 104(6)
Measurement and characterization of subvisible particles (defined here as those ranging in size from 2 to 100 μm), including proteinaceous and nonproteinaceous particles, is an important part of every stage of protein therapeutic development. The to